This Artificial Intelligence Move Is One New Reason to Buy Eli Lilly Stock in 2024
There's no playbook for how to be competitive in artificial intelligence (AI) as a big pharma company, but Eli Lilly ( LLY -1.74%) is taking a shot at developing one. With the appointment of a new chief AI officer, Thomas Fuchs, on Oct. 8, it will now have someone with the purview to direct its AI strategy and implementation.